| Double negative regulatory T cells in transplantation and autoimmunity: recent progress and future directions SC Juvet, L Zhang Journal of molecular cell biology 4 (1), 48-58, 2012 | 172 | 2012 |
| Outcomes of a natural rubber latex control program in an Ontario teaching hospital SM Tarlo, A Easty, K Eubanks, CR Parsons, F Min, S Juvet, GM Liss Journal of Allergy and Clinical Immunology 108 (4), 628-633, 2001 | 161 | 2001 |
| Molecular pathogenesis of lymphangioleiomyomatosis: lessons learned from orphans SC Juvet, FX McCormack, DJ Kwiatkowski, GP Downey American journal of respiratory cell and molecular biology 36 (4), 398-408, 2007 | 122 | 2007 |
| Safety and Efficacy of Ex Vivo Donor Lung Adenoviral IL-10 Gene Therapy in a Large Animal Lung Transplant Survival Model TN Machuca, M Cypel, R Bonato, JC Yeung, YM Chun, S Juvet, Z Guan, ... Human gene therapy 28 (9), 757-765, 2017 | 111 | 2017 |
| Harnessing regulatory T cells for clinical use in transplantation: the end of the beginning SC Juvet, AG Whatcott, AR Bushell, KJ Wood American Journal of Transplantation 14 (4), 750-763, 2014 | 100 | 2014 |
| Rare lung diseases III: Pulmonary Langerhans’ cell histiocytosis SC Juvet, D Hwang, GP Downey Canadian Respiratory Journal 17, e55-e62, 2010 | 92 | 2010 |
| Regulation of antigen‐expressing dendritic cells by double negative regulatory T cells JF Gao, MSF McIntyre, SC Juvet, J Diao, X Li, RB Vanama, TW Mak, ... European journal of immunology 41 (9), 2699-2708, 2011 | 79 | 2011 |
| Mesenchymal stromal cell therapy during ex vivo lung perfusion ameliorates ischemia-reperfusion injury in lung transplantation D Nakajima, Y Watanabe, A Ohsumi, M Pipkin, M Chen, P Mordant, ... The Journal of Heart and Lung Transplantation 38 (11), 1214-1223, 2019 | 72 | 2019 |
| Timing of nocturnal ventricular ectopy in heart failure patients with sleep apnea CM Ryan, S Juvet, R Leung, TD Bradley Chest 133 (4), 934-940, 2008 | 66 | 2008 |
| Successful lung transplantation from hepatitis C positive donor to seronegative recipient B Khan, LG Singer, LB Lilly, C Chaparro, T Martinu, S Juvet, M Pipkin, ... American Journal of Transplantation 17 (4), 1129-1131, 2017 | 55 | 2017 |
| Molecular assessment of rejection and injury in lung transplant biopsies KM Halloran, MD Parkes, J Chang, IL Timofte, GI Snell, GP Westall, ... The Journal of Heart and Lung Transplantation 38 (5), 504-513, 2019 | 52 | 2019 |
| Rare lung diseases II: Pulmonary alveolar proteinosis SC Juvet, D Hwang, TK Waddell, GP Downey Canadian respiratory journal 15, 203-210, 2008 | 49 | 2008 |
| Higher M30 and high mobility group box 1 protein levels in ex vivo lung perfusate are associated with primary graft dysfunction after human lung transplantation K Hashimoto, M Cypel, S Juvet, T Saito, R Zamel, TN Machuca, M Hsin, ... The Journal of Heart and Lung Transplantation 37 (2), 240-249, 2018 | 42 | 2018 |
| Innate control of tissue-reparative human regulatory T cells AJ Lam, KN MacDonald, AM Pesenacker, SC Juvet, KA Morishita, ... The Journal of Immunology 202 (8), 2195-2209, 2019 | 41 | 2019 |
| Circulating cell death biomarkers may predict survival in human lung transplantation K Hashimoto, R Besla, R Zamel, S Juvet, H Kim, S Azad, TK Waddell, ... American journal of respiratory and critical care medicine 194 (1), 97-105, 2016 | 37 | 2016 |
| Molecular phenotyping of rejection-related changes in mucosal biopsies from lung transplants K Halloran, MD Parkes, IL Timofte, GI Snell, GP Westall, R Hachem, ... American Journal of Transplantation 20 (4), 954-966, 2020 | 36 | 2020 |
| AB cell–dependent pathway drives chronic lung allograft rejection after ischemia–reperfusion injury in mice T Watanabe, T Martinu, A Chruscinski, K Boonstra, B Joe, M Horie, ... American Journal of Transplantation 19 (12), 3377-3389, 2019 | 36 | 2019 |
| Extracellular matrix injury of kidney allografts in antibody-mediated rejection: a proteomics study S Clotet-Freixas, CM McEvoy, I Batruch, C Pastrello, M Kotlyar, JAD Van, ... Journal of the American Society of Nephrology 31 (11), 2705-2724, 2020 | 35 | 2020 |
| The impact of first untreated subclinical minimal acute rejection on risk for chronic lung allograft dysfunction or death after lung transplantation L Levy, E Huszti, J Tikkanen, R Ghany, W Klement, M Ahmed, S Husain, ... American Journal of Transplantation 20 (1), 241-249, 2020 | 35 | 2020 |
| Halofuginone treatment reduces interleukin-17A and ameliorates features of chronic lung allograft dysfunction in a mouse orthotopic lung transplant model H Oishi, T Martinu, M Sato, Y Matsuda, S Hirayama, SC Juvet, Z Guan, ... The Journal of Heart and Lung Transplantation 35 (4), 518-527, 2016 | 35 | 2016 |
Tereza MartinuAssistant Professor, University of TorontoVerified email at uhn.ca
